BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36868754)

  • 1. Approach to Disorders of Gut-Brain Interaction.
    Tome J; Kamboj AK; Loftus CG
    Mayo Clin Proc; 2023 Mar; 98(3):458-467. PubMed ID: 36868754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar.
    Kovács DB; Szekely A; Hubai AG; Palsson O
    BMJ Open Gastroenterol; 2022 Aug; 9(1):. PubMed ID: 35953148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of functional gastrointestinal disorders.
    Fikree A; Byrne P
    Clin Med (Lond); 2021 Jan; 21(1):44-52. PubMed ID: 33479067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders.
    Singh R; Zogg H; Ghoshal UC; Ro S
    Front Pharmacol; 2022; 13():808195. PubMed ID: 35145413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlaps with bladder pain syndrome and irritable bowel syndrome are associated with higher symptom burden and reduced quality of life in functional dyspepsia.
    Wuestenberghs F; Baron M; Melchior C; Desprez C; Cornu JN; Leroi AM; Gourcerol G
    Neurogastroenterol Motil; 2022 Nov; 34(11):e14414. PubMed ID: 35608061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding neuroimmune interactions in disorders of gut-brain interaction: from functional to immune-mediated disorders.
    Vanuytsel T; Bercik P; Boeckxstaens G
    Gut; 2023 Apr; 72(4):787-798. PubMed ID: 36657961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional gastrointestinal disorders: advances in understanding and management.
    Black CJ; Drossman DA; Talley NJ; Ruddy J; Ford AC
    Lancet; 2020 Nov; 396(10263):1664-1674. PubMed ID: 33049221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms Underlying Food-Triggered Symptoms in Disorders of Gut-Brain Interactions.
    Van den Houte K; Bercik P; Simren M; Tack J; Vanner S
    Am J Gastroenterol; 2022 Jun; 117(6):937-946. PubMed ID: 35506862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study.
    Halder SL; Locke GR; Talley NJ; Fett SL; Zinsmeister AR; Melton LJ
    Aliment Pharmacol Ther; 2004 Jan; 19(2):233-42. PubMed ID: 14723614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Dyspepsia and Irritable Bowel Syndrome: Beyond Rome IV.
    Stanghellini V
    Dig Dis; 2017; 35 Suppl 1():14-17. PubMed ID: 29421792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorders of gut-brain interaction: Highly prevalent and burdensome yet under-taught within medical education.
    Simons J; Shajee U; Palsson O; Simren M; Sperber AD; Törnblom H; Whitehead W; Aziz I
    United European Gastroenterol J; 2022 Sep; 10(7):736-744. PubMed ID: 35781806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Reported Outcomes in Disorders of Gut-Brain Interaction.
    Tack J; Carbone F; Chang L; Lacy BE
    Gastroenterology; 2024 Apr; 166(4):572-587.e1. PubMed ID: 38309628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.
    Talley NJ; Holtmann G; Walker MM
    J Gastroenterol; 2015 Jun; 50(6):601-13. PubMed ID: 25917563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional dyspepsia leads to more healthcare utilization in secondary care compared with other functional gastrointestinal disorders.
    Chuah KH; Cheong SY; Lim SZ; Mahadeva S
    J Dig Dis; 2022 Feb; 23(2):111-117. PubMed ID: 35050547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the Rome IV Criteria to Functional Dyspepsia Symptoms in Saudi Arabia: Epidemiology and Clinical Practice.
    Zacharakis G; Al-Ghamdi S; AlZahrani J; Almasoud A; Arahmane O; AlShehri A; Alharbi MH; Alsalmi MM; Alotibi SB; Algaradi YA; Alsadiq FN; Nikolaidis P
    Korean J Gastroenterol; 2020 Dec; 76(6):304-313. PubMed ID: 33361706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.
    von Wulffen M; Talley NJ; Hammer J; McMaster J; Rich G; Shah A; Koloski N; Kendall BJ; Jones M; Holtmann G
    Dig Dis Sci; 2019 Feb; 64(2):480-486. PubMed ID: 30368683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asia-Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms.
    Gwee KA; Lee YY; Suzuki H; Ghoshal UC; Holtmann G; Bai T; Barbara G; Chen MH; Chua ASB; Gibson PR; Hou X; Liu J; Nakajima A; Pratap N; Sachdeva S; Siah KTH; Soh AYS; Sugano K; Tack J; Tan VPY; Tang X; Walker M; Wu DC; Xiao YL; Zulkifli KK; Toh C
    J Gastroenterol Hepatol; 2023 Feb; 38(2):197-209. PubMed ID: 36321167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates in functional dyspepsia and bloating.
    Lacy BE; Cangemi DJ
    Curr Opin Gastroenterol; 2022 Nov; 38(6):613-619. PubMed ID: 36219129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet for Functional Gastrointestinal Disorders/Disorders of Gut-Brain Interaction.
    Pomenti S; Devinsky J; Jodorkovsky D
    Med Clin North Am; 2022 Sep; 106(5):899-912. PubMed ID: 36154707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription pain medications for disorders of gut-brain interaction: Comparing usage patterns with clinical practice recommendations.
    LeBrett WG; Chang L
    Neurogastroenterol Motil; 2023 Aug; 35(8):e14645. PubMed ID: 37403519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.